Clinical Trials Browser

Phase 2 × Leukemia, Myeloid, Chronic-Phase × decitabine and cedazuridine drug combination × Clear all

NCT05007873 2026-02-18

ASTX727 and Dasatinib for the Treatment of Newly Diagnosed Philadelphia Chromosome or BCR-ABL Positive Chronic Myeloid Leukemia in Chronic Phase

Phase 2 Recruiting

Other hematologic neoplasm

Leukemia, Myeloid, Chronic-Phase